Should I Buy RHLD? RHLD 2026 Analysis

Should You Buy Resolute Holdings Management Inc (RHLD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

193.100

1 Day change

4.38%

52 Week Range

236.190

Analysis Updated At

2026/01/30

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient investor. RHLD is sitting near its pivot level after a sharp down day, momentum is still mildly bearish (MACD < 0) with no proprietary buy signals, and earnings are imminent (Feb 2 after-hours), which adds near-term event risk. I would wait rather than buy immediately at ~204.51.

Technical Analysis

Trend/price action: RHLD is down -3.27% today (pre-market -1.28%) and trading ~204.51, slightly below the pivot (205.358), which keeps near-term bias cautious. Momentum: MACD histogram is -1.374 (below zero) and negatively contracting—bearish momentum persists but is easing (possible stabilization, not a confirmed reversal). Strength: RSI(6) ~50.6 is neutral, consistent with consolidation rather than a clear uptrend. Moving averages: Converging MAs suggest range-bound trading / indecision. Levels: Resistance R1 ~219.752 then R2 ~228.644; Support S1 ~190.964 then S2 ~182.072. A cleaner buy setup would typically come from reclaiming and holding above the pivot with improving MACD. Pattern-based forward odds: Similar-pattern study suggests modest upside bias (next day +0.75%, next week +1.21%, next month +4.08%), but the edge is small and not supported by a fresh signal today.

Intellectia Proprietary Trading Signals

AI Stock Picker: no signal on given stock today.
SwingMax: No signal on given stock recently.

Positive Catalysts

on 2026-02-02 after-hours could re-rate the stock if results/guide surprise positively.

Neutral/Negative Catalysts

- Near-term technical pressure: price is below the pivot after a notable down day; MACD remains negative.
- Event risk: earnings in the coming days can create sharp moves; not ideal for an impatient “buy now” entry without a clear edge.
- Profitability pressure: EPS and net income are still negative in the latest quarter despite revenue growth.

Financial Performance

Latest quarter provided: 2025/Q3.

Revenue: 120.865M, +12.82% YoY (solid top-line growth).
Gross margin: 59.01%, +13.18% YoY (meaningful margin improvement).
Net income: -0.231M (still slightly negative).
EPS: -0.03, down -108.33% YoY (deterioration versus prior year; profitability trend is not yet convincing). Overall: Growth and margins improved, but earnings power remains weak/negative, which limits near-term “must buy now” conviction.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating trend or price target change data was provided, so a true Wall Street consensus read isn’t available. Wall Street-style pros: accelerating revenue and expanding gross margin; operational focus tied to the GPGI rebrand/segment structure. Wall Street-style cons: EPS deterioration and still-negative profitability; near-term uncertainty into the upcoming earnings report. Influential/insider/political activity: Hedge funds neutral and insiders neutral (no notable trend). Congress trading: no recent data available.

Analyst Rating

Wall Street analysts forecast RHLD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RHLD is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 185.000

Low

Averages

High